• 1
    Nau R, Sörgel F, Prange HW. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35: 223246.
  • 2
    Mindermann T, Zimmerl W, Gratzl O. Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother 1998; 42: 26262629.
  • 3
    Nilsson OG, Brandt L, Ungerstedt U, Saveland H. Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 1999; 45: 11761184.
  • 4
    Hammarlund-Udenaes M. The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Adv Drug Deliv Rev 2000; 45: 283294.
  • 5
    Frossard M, Joukhadar C, Erovic B, et al. Distribution and antimicrobial activity of fosfomycin in the interstitial space fluid of human soft tissues. Antimicrob Agents Chemother 2000; 44: 27282732.
  • 6
    Pfeifer G, Frenkel C, Entzian W. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin. Int J Clin Pharmacol Res 1985; 5: 171174.
  • 7
    Dios-Vieitez MC, Goñi MM, Renedo MJ, Fos D. Determination of fosfomycin in human urine by capillary gas chromatography: Application to clinical pharmacokinetic studies. Chromatographia 1996; 43: 293295.
  • 8
    Paradridge WM. Brain drug transport and blood–brain-barrier transport. Drug Delivery 1993; 1: 83101.